Study of telemedicine in prescribing low dose pills for dysmenorrhea patients

Single center retrospective observational study of telemedicine in prescribing LEP (low dose pills) for dysmenorrhea patients - Single center retrospective observational study of telemedicine in prescribing LEP for dysmenorrhea patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000046405

Enrollment

212

Registered

2021-12-21

Start date

2021-12-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dysmenorrhea

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Common to Both Group 1)Patients with dysmenorrhea whose target period includes the start of LEP and 6 months after the start Telemedicine Group 1)Patients who have had at least one telemedicine within 6 months after the start of LEP In-person care Group 1)Patients who have never had telemedicine and only have had in-person care within 6 months after the start of LEP

Exclusion criteria

Exclusion criteria: Common to Both Group 1)Patients who reject to be included this study 2)One or more LEP prescription contraindications are applicable at the start of prescription In-person care Group 1)Patients who start LEP prescription after the telemedicine system introduction

Design outcomes

Primary

Measure	Time frame
Probability of abnormal uterine bleeding in 6 months after the start of treatment	—

Secondary

Measure	Time frame
Other side effects Continuation rate for treatment Cost burden of patient Treatment effectivity	—

Countries

Japan

Contacts

Public ContactYumi Inoo

Yokohama City University School of Medicine Department of Medial Education

inoo.yum.dk@yokohama-cu.ac.jp045-787-2627

Outcome results